Riskpilot← Back to searchSign inGet full accessPHD Nordic Oy
OYActiveY-tunnus 2343549-6Rinnekatu 17-A3Manufacture of medical and dental instruments and supplies · NACE 3250Est. 20100 employees
Revenue 2024
EUR 0
EBITDA margin
—
+1401% vs 2023
Equity ratio
64.3%
Financial strength
Net profit 2024
EUR 38K
+598% vs 2023
| Revenue | EUR 0 | — |
| EBITDA | EUR 41K | +1401% |
| Net profit | EUR 38K | +598% |
| Total assets | EUR 3K | +1738% |
| Equity | EUR 2K | +105% |
| Employees | 0 | — |
Legal name
PHD Nordic Oy
Y-tunnus number
2343549-6
Legal form
Osakeyhtiö
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
21. kesäkuuta 2010
Share capital
EUR 4 500
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-11-30
Financial year
January – December
Signatory rights
Selvitystilan aikana selvitysmies yksin
Company purpose
Yhtiön toimiala on nesteiden mittaus- / analysointivälineiden, -palvelujen ja ohjelmistojen suunnittelu, valmistus ja myyminen sekä liikkeenjohdon ja toimialan mukainen koulutus, konsultointi ja asiantuntijapalvelu.
Address
Rinnekatu 17-A3
Phone
+3580443494916
Email
ville.rautiainen@phdnordic.eu
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | −4 | 2 | −1 | −0 | 0 |
| Staff expenses | — | — | — | −0 | −0 |
| EBITDA | −10 | −1 | −5 | −3 | 41 |
| Depreciation & amort. | — | — | — | −0 | −0 |
| EBIT | −10 | −1 | −5 | −3 | 41 |
| Net financials | −4 | −4 | −4 | −4 | −2 |
| Profit before tax | −14 | −5 | −8 | −8 | 39 |
| Tax | −0 | −0 | −0 | −0 | 1 |
| Net profit | −14 | −5 | −8 | −8 | 38 |
| Item | 2019 | 2020 | 2021 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 16 | 6 | 0 | 0 | 3 |
| Equity | −276 | −282 | −290 | −49 | 2 |
| Long-term debt | 246 | 188 | 186 | 45 | 0 |
| Short-term debt | 47 | 100 | 104 | 4 | 1 |
| Total debt | 293 | 288 | 290 | 50 | 1 |
EBITDA margin
4139600.0%
This company
15.8%
Market median
+26199900% vs market
20192024
Equity ratio
64.3%
This company
38.2%
Market median
+68% vs market
20192024
Return on equity
1699.3%
This company
18.4%
Market median
+9135% vs market
20192024
Net profit margin
3794600.0%
This company
8.1%
Market median
+46846814% vs market
20192024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192024
Debt / equity
0.56×
This company
0.62×
Market median
+10% vs market
20192024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-11-30
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JP Liquidator | Liquidator | 2024 |
| Former (3) | ||
AS | Audit | 2011 – 2023 |
VA Chief Executive Officer | Chief Executive Officer | 2013 – 2024 |
MA Confidential Clerk | Confidential Clerk | 2011 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Chairperson | 2013 – 2024 | |
| Board of Directors | 2013 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of PHD Nordic Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Antti Sakari Kääriäinen | Audit | 0 companies |
| Jukka Pekka Kärnä | Liquidator | 0 companies |
| Ville Antti Rautiainen | Chief Executive Officer | 0 companies |
| Mikko Antero Ovaska | Confidential Clerk | 0 companies |
| Kalle-Pekka Ilmari Kemppainen | Chairperson | 0 companies |
| Martti Juhana Kauppi | Board of Directors | 0 companies |